150 related articles for article (PubMed ID: 19164120)
1. Existence of the diffusion-perfusion mismatch within 24 hours after onset of acute stroke: dependence on proximal arterial occlusion.
Copen WA; Rezai Gharai L; Barak ER; Schwamm LH; Wu O; Kamalian S; Gonzalez RG; Schaefer PW
Radiology; 2009 Mar; 250(3):878-86. PubMed ID: 19164120
[TBL] [Abstract][Full Text] [Related]
2. Desmoteplase.
Paciaroni M; Medeiros E; Bogousslavsky J
Expert Opin Biol Ther; 2009 Jun; 9(6):773-8. PubMed ID: 19456211
[TBL] [Abstract][Full Text] [Related]
3. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
Kakuda W; Abo M
Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
[TBL] [Abstract][Full Text] [Related]
4. Prediction of subacute infarct size in acute middle cerebral artery stroke: comparison of perfusion-weighted imaging and apparent diffusion coefficient maps.
Drier A; Tourdias T; Attal Y; Sibon I; Mutlu G; Lehéricy S; Samson Y; Chiras J; Dormont D; Orgogozo JM; Dousset V; Rosso C
Radiology; 2012 Nov; 265(2):511-7. PubMed ID: 22923715
[TBL] [Abstract][Full Text] [Related]
5. The Desmoteplase in Acute Ischemic Stroke (DIAS) clinical trial program.
von Kummer R; Albers GW; Mori E;
Int J Stroke; 2012 Oct; 7(7):589-96. PubMed ID: 22989394
[TBL] [Abstract][Full Text] [Related]
6. Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke.
Campbell BC; Christensen S; Levi CR; Desmond PM; Donnan GA; Davis SM; Parsons MW
Stroke; 2012 Oct; 43(10):2648-53. PubMed ID: 22858726
[TBL] [Abstract][Full Text] [Related]
7. Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials.
Warach S; Al-Rawi Y; Furlan AJ; Fiebach JB; Wintermark M; Lindstén A; Smyej J; Bharucha DB; Pedraza S; Rowley HA
Stroke; 2012 Sep; 43(9):2313-8. PubMed ID: 22738918
[TBL] [Abstract][Full Text] [Related]
8. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.
Furlan AJ; Eyding D; Albers GW; Al-Rawi Y; Lees KR; Rowley HA; Sachara C; Soehngen M; Warach S; Hacke W;
Stroke; 2006 May; 37(5):1227-31. PubMed ID: 16574922
[TBL] [Abstract][Full Text] [Related]
9. Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging.
Rovira A; Orellana P; Alvarez-Sabín J; Arenillas JF; Aymerich X; Grivé E; Molina C; Rovira-Gols A
Radiology; 2004 Aug; 232(2):466-73. PubMed ID: 15215546
[TBL] [Abstract][Full Text] [Related]
10. T2' imaging predicts infarct growth beyond the acute diffusion-weighted imaging lesion in acute stroke.
Siemonsen S; Fitting T; Thomalla G; Horn P; Finsterbusch J; Summers P; Saager C; Kucinski T; Fiehler J
Radiology; 2008 Sep; 248(3):979-86. PubMed ID: 18647849
[TBL] [Abstract][Full Text] [Related]
11. Acute ischemic stroke: infarct core estimation on CT angiography source images depends on CT angiography protocol.
Pulli B; Schaefer PW; Hakimelahi R; Chaudhry ZA; Lev MH; Hirsch JA; González RG; Yoo AJ
Radiology; 2012 Feb; 262(2):593-604. PubMed ID: 22187626
[TBL] [Abstract][Full Text] [Related]
12. Combined perfusion- and diffusion-weighted MR imaging in acute ischemic stroke during the 1st week: a longitudinal study.
Karonen JO; Liu Y; Vanninen RL; Ostergaard L; Kaarina Partanen PL; Vainio PA; Vanninen EJ; Nuutinen J; Roivainen R; Soimakallio S; Kuikka JT; Aronen HJ
Radiology; 2000 Dec; 217(3):886-94. PubMed ID: 11110958
[TBL] [Abstract][Full Text] [Related]
13. Acute ischemic stroke: predictive value of 2D phase-contrast MR angiography--serial study with combined diffusion and perfusion MR imaging.
Liu Y; Karonen JO; Vanninen RL; Nuutinen J; Koskela A; Soimakallio S; Aronen HJ
Radiology; 2004 May; 231(2):517-27. PubMed ID: 15044743
[TBL] [Abstract][Full Text] [Related]
14. MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time.
Petkova M; Rodrigo S; Lamy C; Oppenheim G; Touzé E; Mas JL; Méder JF; Oppenheim C
Radiology; 2010 Dec; 257(3):782-92. PubMed ID: 21045177
[TBL] [Abstract][Full Text] [Related]
15. Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase.
Fiebach JB; Al-Rawi Y; Wintermark M; Furlan AJ; Rowley HA; Lindstén A; Smyej J; Eng P; Warach S; Pedraza S
Stroke; 2012 Jun; 43(6):1561-6. PubMed ID: 22474060
[TBL] [Abstract][Full Text] [Related]
16. Acute and subacute ischemic stroke at high-field-strength (3.0-T) diffusion-weighted MR imaging: intraindividual comparative study.
Kuhl CK; Textor J; Gieseke J; von Falkenhausen M; Gernert S; Urbach H; Schild HH
Radiology; 2005 Feb; 234(2):509-16. PubMed ID: 15601894
[TBL] [Abstract][Full Text] [Related]
17. Extension of therapeutic window in ischemic stroke by selective mismatch imaging.
Heiss WD; Zaro-Weber O
Int J Stroke; 2019 Jun; 14(4):351-358. PubMed ID: 30935350
[TBL] [Abstract][Full Text] [Related]
18. Patients with diffusion-perfusion mismatch on magnetic resonance imaging 48 hours or more after stroke symptom onset: clinical and imaging features.
Perez A; Restrepo L; Kleinman JT; Barker P; Beauchamp N; Wityk RJ
J Neuroimaging; 2006 Oct; 16(4):329-33. PubMed ID: 17032382
[TBL] [Abstract][Full Text] [Related]
19. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of MRI perfusion disturbances and normal diffusion in acute stroke patients.
Blondin D; Seitz RJ; Rusch O; Janssen H; Andersen K; Wittsack HJ; Turowski B
Eur J Radiol; 2009 Jul; 71(1):1-10. PubMed ID: 18490126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
